NorthWest Biotherapeutics Inc (NWBO)

[bbking2003]

This is a placebo-controlled study, with two patients out of three receiving standard of care plus the active DCVax vaccine investigational treatment. One out of three will receive standard of care treatment, plus an inactive placebo. However if participants on placebo therapy have any signs of disease progression, they will have the option to cross over to active vaccine investigational treatment. http://www.houstonmethodist.org/tumor-clinical-trials